In fact, a recent report has shown protection against D-galactosamine- and lipopolysaccharide-induced acute inflammation and liver failure by HO1 overexpression through suppression of the NLRP3 signaling pathway (Kim and Lee, 2013). Here, HMOX1 is linked to liver failure.